EPS (Diluted) for Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's current diluted EPS (TTM) is $1.88. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$1.88
YoY change
-73.7%
5Y CAGR
+7.1%
Peak year (2024)
$6.97
Latest annual
$1.83
EPS (Diluted) history chart for Edwards Lifesciences (EW) from 1999 to 2025
EPS (Diluted) history table for Edwards Lifesciences (EW) from 1999 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $1.83 | -73.7% | ||
| 2024 | $6.97 | +203.0% | ||
| 2023 | $2.30 | -5.7% | ||
| 2022 | $2.44 | +2.5% | ||
| 2021 | $2.38 | +83.1% | ||
| 2020 | $1.30 | -20.7% | ||
| 2019 | $1.64 | +45.1% | ||
| 2018 | $1.13 | +17.7% | ||
| 2017 | $0.96 | +10.3% | ||
| 2016 | $0.87 | +16.0% | ||
| 2015 | $0.75 | -40.0% | ||
| 2014 | $1.25 | +119.3% | ||
| 2013 | $0.57 | +39.0% | ||
| 2012 | $0.41 | +24.2% | ||
| 2011 | $0.33 | +6.5% | ||
| 2010 | $0.31 | -6.1% | ||
| 2009 | $0.33 | +83.3% | ||
| 2008 | $0.18 | +12.5% | ||
| 2007 | $0.16 | -11.1% | ||
| 2006 | $0.18 | +63.6% | ||
| 2005 | $0.11 | +4300.0% | ||
| 2004 | $0.00 | -97.7% | ||
| 2003 | $0.11 | +45.1% | ||
| 2002 | $0.08 | -545.9% | ||
| 2001 | $-0.02 | -95.6% | ||
| 2000 | $-0.39 | -425.0% | ||
| 1999 | $0.12 | — |
EPS (Diluted) values are taken from Edwards Lifesciences's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Edwards Lifesciences (EW) diluted EPS is $1.83 – plunged 73.7% year-over-year.
Over 2020–2025 (5 years), Edwards Lifesciences diluted EPS expanded at a +7.1% compound annual rate, with the latest reading among the more recent periods of the dataset.
Edwards Lifesciences diluted EPS peaked at $6.97 in 2024; the latest annual figure is $1.83 in 2025 (73.7% below peak).
2024 marks the peak diluted EPS at $6.97, with the historical low of $-0.39 recorded in 2000.
Edwards Lifesciences (EW) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $13.16.
Edwards Lifesciences EPS (Diluted) by Year
Edwards Lifesciences EPS (Diluted) 2025: $1.83
Edwards Lifesciences diluted EPS in 2025 was $1.83, plunged 73.7% below 2024.
Edwards Lifesciences EPS (Diluted) 2024: $6.97
Edwards Lifesciences diluted EPS in 2024 was $6.97, surged 203.0% from 2023. This figure represents the highest annual value in the available history.
Edwards Lifesciences EPS (Diluted) 2023: $2.30
Edwards Lifesciences diluted EPS in 2023 was $2.30, declined 5.7% below 2022.
Edwards Lifesciences EPS (Diluted) 2022: $2.44
Edwards Lifesciences diluted EPS in 2022 was $2.44, edged up 2.5% from 2021.
Edwards Lifesciences EPS (Diluted) 2021: $2.38
Edwards Lifesciences diluted EPS in 2021 was $2.38.
See more financial history for Edwards Lifesciences (EW).
Sector peers — EPS (Diluted)
Companies in the same sector as Edwards Lifesciences, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Edwards Lifesciences's diluted EPS?
- Latest reported diluted EPS for Edwards Lifesciences (EW) is $1.88 (period ending March 31, 2026).
How has Edwards Lifesciences diluted EPS changed year-over-year?
- Edwards Lifesciences (EW) diluted EPS changed -73.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Edwards Lifesciences diluted EPS?
- Edwards Lifesciences (EW) diluted EPS compound annual growth rate is +7.1% over the most recent 5 years available.
When did Edwards Lifesciences diluted EPS hit its highest annual value?
- Edwards Lifesciences diluted EPS reached its highest annual value of $6.97 in 2024.
What was Edwards Lifesciences diluted EPS in 2024?
- Edwards Lifesciences (EW) diluted EPS in 2024 was $6.97.
What was Edwards Lifesciences diluted EPS in 2025?
- Edwards Lifesciences (EW) diluted EPS in 2025 was $1.83.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
EW Overview
Company profile, financial tools, and key metrics
EW Revenue Counter
Earns $199.88 every second. See per minute, hour, and day.
EW Earnings Counter
Earns $34.65 per second net profit. See per minute, hour, and day.
EW Economic Scale
Exceeds Fiji's GDP. Compare with world economies.
EW What If Invested
What if you had invested $1,000? See historical returns from any date.
EW How It Makes Money
Discover visual breakdown of $6.30B in revenue — where it comes from and where it goes.
EW Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
EW Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
EW Daily Price Character
Balanced · 50.0% historical win rate (green days). Streaks & record days.
EW Buybacks
0.93% TTM buyback yield. Shareholder yield & SBC comparison.
EW Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.